Connexin 43: how a heart protein controls electrical signals and injury response
Connexin-based Signaling in the Heart: Cellular and Exosomal
This work looks at how a heart protein called Connexin 43 and nearby sodium channels help electrical signals travel through the heart and how the protein affects damage after low blood flow, which could point to new ways to treat arrhythmias and heart injury.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Polytechnic Inst and St Univ NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-11252888 on NIH RePORTER |
What this research studies
Researchers will examine how Connexin 43 (Cx43) and interacting sodium channel complexes at the edges of cell contacts contribute to the heartbeat's electrical wiring. The team will use laboratory methods including animal models, molecular and imaging experiments, and analysis of small vesicles (exosomes) and protein fragments to study Cx43 behavior. They will also study how the Cx43 tail region changes the heart's response to ischemic injury (low blood flow). The goal is to connect basic molecular findings to problems like arrhythmias and damage after heart attacks.
Who could benefit from this research
Good fit: People with heart rhythm problems (arrhythmias) or a history of heart attack/ischemic heart disease would be the kinds of patients most likely to benefit from or be involved in related future studies.
Not a fit: People with conditions unrelated to the heart or those seeking an immediate treatment option are unlikely to see direct benefit from this basic-science project.
Why it matters
Potential benefit: If successful, this work could reveal new biological targets for treating heart rhythm disorders and protecting the heart after ischemia.
How similar studies have performed: Prior animal and genetic studies have challenged the traditional connexin-based view of conduction and provided preliminary support for alternate mechanisms, but translating these findings into treatments remains largely unproven.
Where this research is happening
Blacksburg, United States
- Virginia Polytechnic Inst and St Univ — Blacksburg, United States (Active)
Researchers
- Principal investigator: Gourdie, Robert G — Virginia Polytechnic Inst and St Univ
- Study coordinator: Gourdie, Robert G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.